Summary
Background The study “HI-Herz.BIKE Saar” (August 2017 - September 2019) examined the health benefits and training effect of e-bikes (pedelecs) in patients from ambulatory heart groups with moderate chronic heart failure (CHI).
Method 10 subjects with NYHA stage II-III and a left ventricular ejection fraction LVEF of <=50% were selected. The presented study is explicitly marked as a pilot study.
The new HeartGo® system used here for the first time allows heart rate controlled training on a special pedelec via a smartphone app. The groups were accompanied during the training rides by a doctor and a paramedic. No cardiac complications occurred. The training units were increased in duration, distance and target frequency every six months.
Frequency behaviour, pedaling and motor load on the pedelec as well as climatic data such as ejection fraction, a biomarker (NT-pro BNP), risk factors, arterial blood pressure and ergometric courses were measured.
Results The power tolerance increased by almost 2.5 times, a discrete decrease of the resting heart rate by 3.7% was observed and pedaling power improved accordingly. In the clinical data the ergometric power increased by 44% and the LVEF improved by 29%. The NT-pro BNP value decreased by 27%. Body Mass Index BMI remained constant at 27 and cholesterol levels showed no significant changes.
Conclusions Pedaling according to this pilot study with its methodological limitations of low number was safe and accompanied by significant health benefits. The subjects were enthusiastic and satisfied with this form of training. This training form can therefore be recommended to heart group participants under certain medical conditions and can be used in the training process. The results of this pilot study with its methodological weaknesses should be verified in a larger follow-up study.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Number of registration: DRKS00022829 https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022829
Clinical Protocols
https://herz-bike-saar.ghennersdorf.net/
Funding Statement
the study has not been funded
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee: The study was accepted by the Ethics Committee of the Medical Association of the Saarland on April 18, 2018: "With reference to point 2 of the statute of the Ethics Commission at the Medical Association of the Saarland, there are no objections to the implementation of the intended research project".
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
